Biosimilars for the management of rheumatoid arthritis: economic considerations
Biosimilars for the management of rheumatoid arthritis: economic considerations is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Biosimilars for the management of rheumatoid arthritis: economic considerations have?
Biosimilars for the management of rheumatoid arthritis: economic considerations has 95 citations in the OpenAlex counts ScholarIQ stores.
When was Biosimilars for the management of rheumatoid arthritis: economic considerations published?
Biosimilars for the management of rheumatoid arthritis: economic considerations has 2015 year in the ScholarIQ index.
What is the open-access status of Biosimilars for the management of rheumatoid arthritis: economic considerations?
Biosimilars for the management of rheumatoid arthritis: economic considerations has bronze oa status in the ScholarIQ index.
What is the DOI of Biosimilars for the management of rheumatoid arthritis: economic considerations?
The DOI for Biosimilars for the management of rheumatoid arthritis: economic considerations is on the source record.
What is the PMID of Biosimilars for the management of rheumatoid arthritis: economic considerations?
The PMID for Biosimilars for the management of rheumatoid arthritis: economic considerations is on the source record.
What is the OpenAlex record for Biosimilars for the management of rheumatoid arthritis: economic considerations?
The OpenAlex for Biosimilars for the management of rheumatoid arthritis: economic considerations is on the source record.